Haleon PLC Updates Total Voting Rights and Share Capital

Haleon PLC ( (GB:HLN) ) has shared an announcement.

Haleon PLC announced that as of May 31, 2025, it has issued a total of 9,005,330,185 ordinary shares, with 4,080,205 held as treasury shares. This results in 9,001,249,980 shares having voting rights, a figure crucial for shareholders and others with notification obligations under the FCA’s Disclosure Guidance and Transparency Rules. This update is significant for stakeholders as it impacts the calculation of their interests in the company.

The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.

Spark’s Take on GB:HLN Stock

According to Spark, TipRanks’ AI Analyst, GB:HLN is a Outperform.

Haleon PLC’s strong financial performance and strategic corporate actions, such as share buybacks, underpin its solid stock position. The technical indicators suggest a positive but potentially overbought market trend, while the valuation hints at overvaluation concerns. The company’s growth outlook remains optimistic due to its performance in emerging markets and innovative products, though challenges like currency headwinds and sector-specific downturns could impact future performance.

To see Spark’s full report on GB:HLN stock, click here.

More about Haleon PLC

Haleon PLC is a global leader in consumer health, focusing on delivering better everyday health with a human touch. The company offers a diverse product portfolio across six major categories: Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. Haleon is known for its trusted brands like Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren, which are grounded in scientific innovation and a deep understanding of human needs.

Average Trading Volume: 27,628,330

Technical Sentiment Signal: Buy

Current Market Cap: £37.26B

For a thorough assessment of HLN stock, go to TipRanks’ Stock Analysis page.